Hints and tips:
...AstraZeneca has made production deals with Russian drugmaker R-Pharm, Fiocruz of Brazil and the Serum Institute of India....
Pharm group’s patent loss will be the gain of healthcare funders
...Both SK D&D, SK Group’s property development unit, and Kyongbo Pharm saw their stock prices more than double on their trading debut....
Economists suggest offshore activity has given misleading picture of health
...Drug developer Phyto-pharm slumped 81 per cent to 1.9p after mid-stage trials of its Parkinson’s disease treatment showed it was no better than a placebo....
...Also in late 2012, Alma Pharma and Turkey’s Abdi Ibrahim Global Pharm announced plans to build a $60m factory in the country....
...Neopharm, founded over 50 years ago, is the 51st-largest company in Israel, according to Dunn & Bradstreet. The broker estimated a take-out valuation of 567p a share....
...The UK company will acquire a 50 per cent stake in GP Corp through a partnership with Beijing Med-Pharm Corporation, a US-listed pharmaceutical marketing and distribution company with “significant experience...
...A new UK vehicle, Alliance BMP, has Beijing Med-Pharm, a US listed “fixer” for western pharmaceutical companies wishing to sell their products in China, as 20 per cent junior partner....
International Edition